In a break with previous administration, new Treasurer Brad Briner says higher premiums, not legislative fixes, needed for State Health Plan.

As the new year sparks a wave of weight loss resolutions and millions turn to weight loss medications, rising costs and the growing popularity of compounded alternatives have raised critical questions ...

Stay updated on the latest potential FDA drug approvals in 2025, including an expanded label for Ozempic and new, nonopioid painkillers.

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet ...

Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...

While obesity product sales will be driving the boon in 2025, industry experts are also eyeing promising new launches in ...

Shaelyn Weaver, after struggling with weight issues due to PCOS and pre-diabetes, embarked on a significant weight loss ...

About 422 million people worldwide have diabetes, according to the WHO, and most of them live in low- or middle-income ...

As we embark on 2025, the health care industry, providers and patients should be prepared for a lot of innovation, and not a ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

In 2024, the state experienced developments in healthcare that will play out in 2025. Ten of them should be on your radar.